Microbots for Drug delivery and monitoring Application-(BODEGA)
Reference number | |
Coordinator | Uppsala universitet - Uppsala universitet Inst för elektroteknik |
Funding from Vinnova | SEK 1 000 000 |
Project duration | September 2023 - May 2024 |
Status | Completed |
Venture | Emerging technology solutions |
Call | Emerging technology solutions stage 1 2023 |
Important results from the project
The aim of the BODEGA project was to develop a proof of concept of a soft miniature robot that can move autonomously through complex pathways similar to the human vascular system and that can perform targeted therapies useful for cardiovascular and cancer treatments. Considerations were also made to ensure that the technologies developed in the project would result in the creation of affordable and sustainable devices that will help deliver efficient and quality robotic treatments to large populations and provide gender equal treatment through customisation.
Expected long term effects
The BODEGA project developed a versatile microbot for navigating autonomously through phantom channels mimicking human vascular systems and performing targeted interventions. Validated in both fluid-filled 3D printed and phantom vascular channels Its amphibious capability effectively navigates intricate pathways. Equipped with a needle-pointed tool, the microbot demonstrates microsurgical precision through individual limb movements, performing tasks like incisions and injections. These advancements promise enhanced minimally invasive and targeted treatments.
Approach and implementation
The fabrication of the BODEGA microbot was made through hybrid additive manufacturing for rapid, low cost and customisable production.The customisable and scalable property of the developed robot allows gender equal treatments by accomodating the specific needs equally. A three-layer cylindrical model was simulated for the vascular channels and was optmised for Fat intrabody communication. The microbot’s autonomous locomotion was refined to navigate simulated and dynamic vascular systems effectively. The robot developed is fully biocompatible and sustainable.